https://pubmed.ncbi.nlm.nih.gov/14961584/
Perfusion of 99Tcm-labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that...
There is strong published and unpublished evidence that our CD105 Mab E9, which is highly reactive with angiogenic endothelial cells, could be a useful reagent...